跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EBILFUMIN 30 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EBILFUMIN 30 MG CAPSULAS DURAS EFG
Approved
STANDARD
EBILFUMIN 30 MG CAPSULAS DURAS EFG
Actavis Group Ptc Ehf.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 8, 2020
Approval ID
a4afce4f0100c34c
Company
Actavis Group Ptc Ehf.
Type
Standard
Approval Details
Approval Id
a4afce4f0100c34c
Drug Cima Aemps Name
EBILFUMIN 30 MG CAPSULAS DURAS EFG
Register Number
1140915001
Holder Company Name
Actavis Group Ptc Ehf.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/actavis-group-ptc-ehf
Authorization Date
2020-06-08
Dosage Form
CÁPSULA DURA
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Actavis Group Ptc Ehf.
Company Detail Path
/organization/actavis-group-ptc-ehf
Company Information
Pharmaceutical Company Name
Actavis Group PTC ehf
Name En
Actavis Group PTC ehf
Country Name
Norway
City Name
lierskogen,buskerud,country_no
Address
c/o Actavis Norway AS Gjellebekkstubben 10
Active Ingredients
OSELTAMIVIR FOSFATO
39.4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 8, 2020
Approval ID
a4afce4f0100c34c
Type
Standard
Back to CIMA-AEMPS Approvals